Skip to content
Friday, July 1, 2022
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending

BIOTCHNO

BIOTCHNO General 

Sierra Oncology to Host KOL Panel Event to Discuss Updated Phase 3 Myelofibrosis Data Presented at ASH

December 1, 2020April 16, 2021 vanessa

Canada NewsWire VANCOUVER, BC, Dec. 1, 2020 –Sierra Chief Development Officer Barbara Klencketo be joined by renowned myelofibrosis experts Jean-Jacques

Read more
BIOTCHNO General 

Nova Mentis Life Science Completes Acquisition of Pilz Bioscience/

November 30, 2020April 8, 2021 vanessa

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}   Canada NewsWire VANCOUVER, BC, Nov. 30, 2020 VANCOUVER, BC,Nov. 30, 2020/CNW/ –Nova Mentis Life Science Corp.(CSE: NOVA) (FSE: HN3Q)

Read more
BIOTCHNO General 

Nova Mentis Life Science Completes Acquisition of Pilz Bioscience

November 30, 2020April 8, 2021 vanessa

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}   Canada NewsWire VANCOUVER, BC, Nov. 30, 2020 VANCOUVER, BC,Nov. 30, 2020/CNW/ –Nova Mentis Life Science Corp.(CSE: NOVA) (FSE: HN3Q)

Read more
BIOTCHNO General 

Sirona Biochem Releases CEO Letter to Shareholders/

November 30, 2020April 8, 2021 vanessa

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}   Canada NewsWire VANCOUVER, BC, Nov. 30, 2020 VANCOUVER, BC,Nov. 30, 2020/CNW/ –Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC:

Read more
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa

Canada NewsWire FREDERICTON, NB, Nov. 30, 2020 FREDERICTON, NB,Nov. 30, 2020/CNW/ – Biotechnology front-runner LuminUltra today announced the acquisition of

Read more
BIOTCHNO General 

Eisai to Present Latest Data on Perampanel at the 74th American Epilepsy Society Annual Meeting

November 30, 2020April 8, 2021 vanessa

Eisai to Present Latest Data on Perampanel at the 74th American Epilepsy Society Annual Meeting TOKYO, Nov 30, 2020 –

Read more
BIOTCHNO Pharma 

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

November 30, 2020April 8, 2021 vanessa

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies TOKYO, Nov 30, 2020 – (JCN

Read more
BIOTCHNO Trending 

AbbVie and Eisai Announce an approval for additional indication of HUMIRA

November 27, 2020May 24, 2021 vanessa

AbbVie and Eisai Announce an approval for additional indication of HUMIRA TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie

Read more
BIOTCHNO General 

The Valens Company Announces Change to its Board of Directors

November 26, 2020April 8, 2021 vanessa

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prntac{TEXT-ALIGN: CENTER}   Canada NewsWire KELOWNA, BC, Nov. 26, 2020 Ms.Renee Merrifieldsteps down following her election as MLA ofKelowna–Missiondistrict inBritish

Read more
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa

Canada NewsWire ST-HYACINTHE, QC, Nov. 26, 2020 ST-HYACINTHE, QC, Nov. 26, 2020 /CNW Telbec/ – It took nearly 10 years of

Read more
  • ← Previous
  • Next →

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057